tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Stock WebsitesTop Gainers/ Losers/ Active StocksDividend StocksChatGPT Stocks
ETFs
ETF CenterTop ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Crypto CenterBitcoin
Popular
Ethereum
Options
Options Market Overview Unusual Options Activity
Popular
Most Active OptionsOptions Volume Leaders
Research Tools
Stock ScreenerETF Screener
Popular
Compare StocksCompare ETFsTrending StocksTechnical Analysis ScreenerPenny Stock ScreenerDaily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement Calculator
New
Mortgage Calculator
Popular
Compound Interest CalculatorStudent Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Stock Websites
Top Gainers/ Losers/ Active Stocks
Dividend Stocks
ChatGPT Stocks
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Research Tools
Stock Screener
ETF Screener
Popular
Compare Stocks
Compare ETFs
Trending Stocks
Technical Analysis Screener
Penny Stock Screener
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

LIFE Stock Latest News

aTyr Pharma’s efzofitimod shows immune function in rheumatoid arthritis
The FlyaTyr Pharma’s efzofitimod shows immune function in rheumatoid arthritis
21d ago
LIFE
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
Press ReleasesaTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
21d ago
LIFE
aTyr Pharma files $300M mixed securities shelf
The FlyaTyr Pharma files $300M mixed securities shelf
25d ago
LIFE
aTyr Pharma reports Q3 EPS (20c), consensus (23c)
The FlyaTyr Pharma reports Q3 EPS (20c), consensus (23c)
25d ago
LIFE
aTyr Pharma to Present at November Investor Conferences
Press ReleasesaTyr Pharma to Present at November Investor Conferences
1M ago
LIFE
aTyr Pharma announces dosing of first patient in Phase 2 EFZO-CONNECT study
The FlyaTyr Pharma announces dosing of first patient in Phase 2 EFZO-CONNECT study
1M ago
LIFE
aTyr Pharma presents efzofitimod data
The FlyaTyr Pharma presents efzofitimod data
3M ago
LIFE
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
Press ReleasesaTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
3M ago
LIFE
aTyr Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Press ReleasesaTyr Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference
3M ago
LIFE
aTyr Pharma reports Q2 EPS (22c), consensus (28c)
The FlyaTyr Pharma reports Q2 EPS (22c), consensus (28c)
4M ago
LIFE
aTyr Pharma price target raised to $20 from $13 at Piper Sandler
The FlyaTyr Pharma price target raised to $20 from $13 at Piper Sandler
5M ago
LIFE
aTyr Pharma downgraded to Perform at Oppenheimer on few material catalysts
The FlyaTyr Pharma downgraded to Perform at Oppenheimer on few material catalysts
5M ago
LIFE
aTyr Pharma downgraded to Perform from Outperform at Oppenheimer
The FlyaTyr Pharma downgraded to Perform from Outperform at Oppenheimer
5M ago
LIFE
aTyr Pharma announcse EC granted ODD for efzofitimod
The FlyaTyr Pharma announcse EC granted ODD for efzofitimod
6M ago
LIFE
aTyr Pharma to present on efzofitimod at WASOG conference
The FlyaTyr Pharma to present on efzofitimod at WASOG conference
6M ago
LIFE
aTyr Pharma to Present on Lead Therapeutic Candidate Efzofitimod at the World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG) Conference
Press ReleasesaTyr Pharma to Present on Lead Therapeutic Candidate Efzofitimod at the World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG) Conference
6M ago
LIFE
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesaTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6M ago
LIFE
aTyr Pharma to Present at the 2023 Jefferies Healthcare Conference
Press ReleasesaTyr Pharma to Present at the 2023 Jefferies Healthcare Conference
6M ago
LIFE
3 Best Stocks to Buy Now, 5/23/2023, According to Top Analysts
Stock Analysis & Ideas3 Best Stocks to Buy Now, 5/23/2023, According to Top Analysts
7M ago
BABA
DSKE
aTyr Pharma presents preclinical research on treatment with ATYR2810 at AACR
The FlyaTyr Pharma presents preclinical research on treatment with ATYR2810 at AACR
8M ago
LIFE
aTyr Pharma price target raised to $13 from $9 at Piper Sandler
The FlyaTyr Pharma price target raised to $13 from $9 at Piper Sandler
8M ago
LIFE
aTyr Pharma announces first major review article for Efzofitimod
The FlyaTyr Pharma announces first major review article for Efzofitimod
8M ago
LIFE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >